Tonic-Clonic Seizures Treatment Market Trends There is a growing trend towards the use of combination therapies to manage tonic-clonic seizures. Combining multiple anti-seizure medications or ...

The FDA also approved Vimpat Injection for use in pediatric patients 4 years of age and older. The Food and Drug Administration (FDA) has approved Vimpat ® (lacosamide; UCB) as adjunctive therapy in ...

Researchers have discovered supplementing a normal, carbohydrate-rich diet with specific ketogenic agents may significantly delay tonic-clonic seizures caused by exposure to high levels of oxygen. The ...

WASHINGTON -- Technologies to provide instant at-home detection of life-threatening seizures and that could allow epilepsy patients to monitor their own drug levels are on the horizon, researchers ...

Eisai announced results from a Phase 3 Study 332 trial of perampanel, an AMPA receptor antagonist in patients with primary generalized tonic-clonic (PGTC) seizures. Study 332 was a double-blind, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. DENVER — Primary generalized tonic-clonic seizures ...

ATLANTA, June 24, 2024 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that Epilepsia published findings from a comprehensive scoping review examining the efficacy of ...

The leading cause of death in epilepsy is rarely explained to patients by doctors, a grieving father has said. Martin Walker ...

GlaxoSmithKline’s antiseizure drug, Lamictal® (lamotrigine), was approved for a new epilepsy indication—one of the most serious forms of epilepsy, primary generalized tonic-clonic (PGTC) seizures.